Actively Recruiting
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank for Head and Neck Disorders
Led by National Institute on Deafness and Other Communication Disorders (NIDCD) · Updated on 2025-11-14
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying various disorders of the head and neck that may affect hearing, balance, smell, taste, swallowing, voice, or speech. These conditions include cancers, genetic, and inflammatory diseases. The study aims to collect biological samples to create a repository that will support research into better diagnosis and treatment methods for these disorders. Participants of all ages who have head and neck conditions may provide leftover tissue samples from routine care or other studies. Those aged 3 years and older may give blood, saliva, and cheek cell samples. Participants aged 18 and older might also provide nasal secretions and have small biopsies of skin and mouth tissue collected. These samples may be used for genetic and molecular research. During the study, researchers will collect clinical data such as age, diagnosis, and prior treatments. Physical exams will be performed for participants aged 3 and above. Samples and information will help create a biorepository that supports ongoing and future studies on normal and diseased tissues. This observational study continues over time and involves no investigational treatments, focusing on sample collection and data gathering.
CONDITIONS
Brief Title
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to provide own consent or have a parent/guardian consent if a minor
- Willingness to sign a written informed consent document
- Have a hearing, balance, smell, taste, voice, speech, or language condition under clinical care or research protocol
- Healthy volunteers aged at least 3 years enrolled on an approved research protocol
You will not qualify if you...
- Active symptomatic major organ disorders increasing biopsy risk, such as bleeding disorders, ischemic heart disease, recent heart attack, congestive heart failure, or severe lung dysfunction
- Medical conditions causing bleeding tendencies that increase risks with biopsies or blood draws, as determined by the principal investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Ongoing throughout participant involvement
Participants provide biospecimens such as blood, saliva, oral swabs, nasal secretions, and biopsies depending on age and clinical condition. Specimens are collected from surgical waste materials when available.
Visits occur as needed for specimen collection during clinical care or research protocols
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
M
Maame S Akumatey
J
Joshua M Levy, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here